Thursday, December 11, 2014

Cat Care Society Gift Wrappers Head to the LoDo Tattered Cover: Dec 14-21

December 14-21, Cat Care Society volunteers will again be wrapping gifts at the Historic LoDo location of Denver's iconic Tattered Cover Book Store, 1628 16th Street. Gift wrapping is free but tips are greatly appreciated and will be donated to the Cat Care Society shelter.

CCS volunteers will be in charge of the Tattered Cover's gift wrapping station on the following days: 

Sunday, December 14, 10 am to 4 pm

Monday, December 15, 10 am to 4 pm

Tuesday, December 16, 10 am to 4 pm

Wednesday, December 17, 10 am to 4 pm

Thursday, December 18, 10 am to 4 pm

Friday, December 19, 10 am to 4 pm

Saturday, December 20, 10 am to 4 pm

Sunday, December 21, 1 pm to 4 pm

 

Tuesday, November 25, 2014

Media Coverage: 'Kevin M. Smith to Retire as President & CEO of CID4; Search Committee Formed to Hire Smith’s Successor'

Coverage overview:


"The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has begun a search for a new Executive Director, as Kevin M. Smith leaves as part of a planned retirement."
Link to BioPortfolio
"Kevin M. Smith will step down from his position as president and chief executive of the Colorado Institute for Drug, Device and Diagnostic Development, also known as CID4, on Dec. 31. The nonprofit bioscience charity has formed a search committee to find a new CEO, CID4 board Chairman Steve Orndorff said. Smith will be available through February to assist during the transition." Link to BizWest

Monday, November 24, 2014

TechFlash: 'Colorado bioscience organization searches for new leadership'

Quoting from today's Denver Business Journal posting by Greg Avery:

"The Colorado Institute for Drug, Device and Diagnostic Development is looking for a new CEO in advance of the retirement of Kevin Smith, the nonprofit group's current leader.

Smith is a co-founding executive of the Aurora-based nonprofit, known as CID4, that was started to help fill a gap in funding for bioscience startups. CID4 identifies and helps fund early-stage Colorado bioscience companies that have the potential to grow and create local jobs.

Smith, a former president of Gambro U.S.A., a Lakewood-based medical device company, plans to retire Dec. 31. He'll be available to the organization through February to help in the transition, the organization said. The CID4 board has formed a CEO search committee."

Link to the Denver Business Journal

InnovatioNews: 'Kevin Smith to retire from leadership of Colorado Institute for Drug, Device and Diagnostic Development on Dec. 31'

Quoting from this morning's posting:

"Kevin M. Smith, president and CEO of the Colorado Institute for Drug, Device and Diagnostic Development (CID4) since 2010, will retire from his post on Dec. 31.

Steve Orndorff, chairman of the CID4 board and president and CEO of Micobiome Therapeutics, said the board has formed a search committee and that Smith will remain available through February 2015 to assist in a smooth transition for CID4’s new executive director...

...CID4 said all inquiries should be directed to the CID4 Search Committee at jobs@cid4.com. Deadline to apply is Dec. 20."

Link to InnovatioNews

DeviceSpace: 'Kevin M. Smith To Retire As President & CEO Of The Colorado Institute For Drug, Device And Diagnostic Development; Search Committee Formed To Hire Smith’s Successor'

Quoting from this morning's posting:

"Kevin M. Smith, President and CEO of the Colorado Institute for Drug, Device and Diagnostic Development (CID4) since 2010, will retire from his position as Chief Executive Officer on December 31, 2014. The announcement is made by Steve Orndorff, PhD, Chairman of the CID4 Board and President & CEO of MicroBiome Therapeutics, who says the CID4 Board has formed a search committee and that Smith will be available through February 2015 to assist in a smooth transition for the new Executive Director."

Link to DeviceSpace

Well-known Life Science Executive Kevin M. Smith to Retire as President/CEO of Colorado Institute for Drug, Device and Diagnostic Development; Search Committee Formed to Hire Smith’s Successor

Kevin M. Smith to Retire as President & CEO of the Colorado Institute for Drug, Device and Diagnostic Development; Search Committee Formed to Hire Smith’s Successor

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has begun a search for a new Executive Director, as Kevin M. Smith leaves as part of a planned retirement. Mr. Smith will remain with CID4 through February 2015 to ensure a smooth and successful transition for CID4’s new leader.

Aurora, CO November 24, 2014 – Kevin M. Smith, President and CEO of the Colorado Institute for Drug, Device and Diagnostic Development (CID4) since 2010, will retire from his position as Chief Executive Officer on December 31, 2014. The announcement is made by Steve Orndorff, PhD, Chairman of the CID4 Board and President & CEO of MicroBiome Therapeutics, who says the CID4 Board has formed a search committee and that Smith will be available through February 2015 to assist in a smooth transition for the new Executive Director.

“With the ongoing changes in the healthcare and life science sectors, CID4 is revisiting how it can best support our industry,” Orndorff said. “CID4 is well positioned for its future and we believe the new Executive Director position will strengthen our alignment with the State of Colorado in our mutual quest to create new jobs and business opportunities within the dynamic life science sector of advanced industries.”

All inquiries should be directed to the ‘CID4 Search Committee’ at jobs@cid4.com. The deadline for applications is December 20, 2014. Principals only need apply, please.

About Kevin M. Smith, CID4 President/CEO

Smith was part of the team that founded CID4 in 2009. Prior to CID4, Smith was President of Gambro, Inc., the U.S. holding company for Gambro AB, the Sweden-based medical device and healthcare services company. He started his career with Arthur Young in New York and was a partner with Ernst & Young, leading the development of their Colorado life science practice at the time he left to join Gambro.

“While I will no longer be leading CID4, I will stay active in the Colorado life science community through my Board responsibilities at the Colorado BioScience Association, Donor Alliance and AlloSource, my service on the Centura Health Audit and Corporate Responsibility Committee and my investment activities at KMG Capital Partners LLC,” Smith said. “CID4’s success is grounded in the excellent technologies that are being developed in Colorado. We have invested approximately $3 million into nine early stage companies. Those firms have gone on to create 85 new jobs and raise an additional $30 million to support the commercialization of their patient-focused technologies. I am proud to have played a role in this process.”

About the Colorado Institute for Drug, Device and Diagnostic Development

Founded in 2009, the Colorado Institute for Drug, Device and Diagnostic Development (CID4) is a 501(c)(3) not-for-profit charitable organization whose mission is to advance the Colorado bioscience ecosystem through company creation and job growth. Active business management and capital work in tandem to help bridge the gap between discovery and product development. CID4 works to identify, fund and actively manage emerging life science technologies. This aim is achieved via an ongoing technology solicitation process augmented by additional deal flow sourcing through networked relationships. Active due diligence is provided by CID4 management in consultation with members of the CID4 Technical and Business Advisory Committee. For more information visit http://CID4.com

Contacts:

Kevin M. Smith, President/CEO CID4, http://CID4.com - kevin.smith@cid4.com, (720) 859-4047

Maggie Chamberlin Holben, APR, http://www.absolutelypr.com - maggie@absolutelypr.com, (303) 984-9801 or (303) 669-3558

Link to the PitchEngine social media release

Link to the PR.com posting

Saturday, November 22, 2014

Colorado BioScience November Focus Newsletter: Featuring DaVita Clinical Research & CBSA 2014 Award Winners

The November Colorado BioScience Focus Newsletter is now available, with DaVita Clinical Research as the Company Spotlight and a full overview of the 2014 CBSA Award Winners.

"DaVita Clinical Research (DCR) brings a track record of success to your Phase I studies. For more than 25 years, DaVita has helped over 150 biopharmaceutical and device clients successfully manage and execute early phase clinical trials in both healthy normal volunteers and patient populations. DaVita's integrated clinical data analysis and reporting offering allows for effective and timely decisions about safety and efficacy." Link to read full the article

Link to download the entire November Focus Newsletter.

Friday, November 14, 2014

Video Highlights: 2014 CBSA Awards Dinner

Colorado BioScience Association announced winners of its 11th annual industry awards at the Marriott City Center, Denver, on November 6th. The announcement is made by April Giles, CBSA President and CEO, who opened the evening with an overview of this year’s industry accomplishments. Giles was joined by 850 KOA’s Steffan Tubbs and CBSA Board Chair Derek Cole in announcing the winners. For more information, visit: http://www.businesswire.com/news/home/20141020005183/en/Colorado-BioScience-Association-Honors-Industry#.VGZWIvnF98E
 
Colorado Bioscience Industry: 2014 Accomplishments
http://youtu.be/GJAPrxe8Enc
 
CBSA Awards Emcee Steffan Tubbs Opening Remarks
http://youtu.be/P_f1wLPrUYg
 
Presentation of the 2014 Boettcher Investigators
http://youtu.be/LBcMi1Y6tVg
 
CBSA Awards 2014 Recipients

http://youtu.be/MFh5B2ibGKo
 
Chairman's Award: Derek Cole Presents
http://youtu.be/18fsXfwddrI
 
CBSA Lifetime Achievement: Dr Richard Duke Remarks
http://youtu.be/6FQ1yqz8T7s
 
Davis Phinney Introduction by Bob Reddy, Medtronic
http://youtu.be/xj5ggFi2rck
 
2014 CBSA Awards Keynote: Davis Phinney
http://youtu.be/Ux82IQayzPU
 
CBSA Awards 2014 Closing: Patients are the Reason
http://youtu.be/xj5ggFi2rck

Coverage overview: CBSA's 2014 Colorado Bioscience Industry Awards

Recapping "Centennial’s AlloSource is the 2014 BioScience Company of the Year, Boulder’s ViroCyt is the industry’s Rising Star and Dr. Richard Duke is honored with CBSA’s Lifetime Achievement Award" coverage:








Link to CNBC.com








Link to BioSpace






Link to Yahoo! Finance






Link to News-Medical.net

Thursday, November 13, 2014

Xconomy: Colorado Bioscience "Companies Take a Bow"

Quoting from the November 7th edition:

"Colorado bioscience’s best: The Colorado BioScience Association also honored their industry’s leaders this week. AlloSource, which is a nonprofit organization based in Centennial, was named company of the year by the association.

AlloSource develops and distributes tissues that can be used in surgical procedures such as skin grafts and joint repair. It has more than 400 employees.

This year, AlloSource expanded its work in stem cell research and began using microbe detection technology developed by NASA’s Jet Propulsion Laboratory to improve tissue decontamination procedures. AlloSource’s hope is that the NASA technology will cut the time it takes to get donated tissue and organs to recipients.

Boulder-based ViroCyt won the award for rising star of the year. The company’s Virus Counter is able to calculate a virus’ growth rate in minutes and is used in vaccine and drug development, viral therapeutics, and protein expression research.

For a list of individual winners, click here."

Link to Xconomy

InnovatioNews: "CBSA's 11th annual awards presented to eight bioscience industry leaders and supporters"

Quoting from InnovatioNews:

"Colorado BioScience Association (CBSA) announced the winners of its 11th annual industry awards during a Thursday [Nov 6] celebration of the state’s bioscience industry at the Marriott City Center in downtown Denver.

April Giles, CBSA president and CEO, along with 850 KOA’s Steffan Tubbs and CBSA Board Chair Derek Cole, announced this year’s award winners:

Company of the Year – AlloSource 
Rising Star of the Year—ViroCyt 
Lifetime Achievement – Dr. Richard Duke 
Institute Leadership – Jim Rosa 
Business Partner of the Year—Phyllis Arthur 
Educator of the Year – Deborah Carnevale 
Volunteer of the Year – Amy Wedeking Shannon 
Chairman’s Award – Monisha Merchant 

In addition to the awards, the event included the Boettcher Foundation presenting its 2014 Class of Boettcher Investigators in the Webb-Waring Boiomedical Research Program."

Link to InnovatioNews